Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCheckit Regulatory News (CKT)

Share Price Information for Checkit (CKT)

Share Price is delayed by 15 minutes
Get Live Data
21.50    -0.50 (-2.27%)
Bid:
21.00
Ask:
22.00
Spread: 1.00 (4.762%)
Market Cap: £23.22m
CKT Live PriceLast checked at - London Stock Exchange

Intraday Checkit Share Chart

Form 8.3 - Checkit Plc

12 Feb 2025 14:34

Form 8.3 - Checkit Plc

8.3

PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORERule 8.3 of the Takeover Code (the “Code”)

1. KEY INFORMATION

(a) Full name of discloser:Rathbones Group Plc
(b) Owner or controller of interests and short positions disclosed, if different from 1(a): The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named. 
(c) Name of offeror/offeree in relation to whose relevant securities this form relates: Use a separate form for each offeror/offereeCheckit Plc
(d) If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree: 
(e) Date position held/dealing undertaken: For an opening position disclosure, state the latest practicable date prior to the disclosure11/02/2025
(f) In addition to the company in 1(c) above, is the discloser making disclosures in respect of any other party to the offer? If it is a cash offer or possible cash offer, state “N/A”Yes – Crimson Tide Plc

2. POSITIONS OF THE PERSON MAKING THE DISCLOSURE

If there are positions or rights to subscribe to disclose in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 2(a) or (b) (as appropriate) for each additional class of relevant security.

(a) Interests and short positions in the relevant securities of the offeror or offeree to which the disclosure relates following the dealing (if any)

Class of relevant security:5p Ord
 InterestsShort positions
 Number%Number%
(1) Relevant securities owned and/or controlled:22,4970.02%  
(2) Cash-settled derivatives:    
(3) Stock-settled derivatives (including options) and agreements to purchase/sell:    
TOTAL:22,4970.02%  

All interests and all short positions should be disclosed.

Details of any open stock-settled derivative positions (including traded options), or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8 (Open Positions).

(b) Rights to subscribe for new securities (including directors’ and other employee options)

Class of relevant security in relation to which subscription right exists: 
Details, including nature of the rights concerned and relevant percentages: 

3. DEALINGS (IF ANY) BY THE PERSON MAKING THE DISCLOSURE

Where there have been dealings in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 3(a), (b), (c) or (d) (as appropriate) for each additional class of relevant security dealt in.

The currency of all prices and other monetary amounts should be stated.

(a) Purchases and sales

Class of relevant securityPurchase/saleNumber of securitiesPrice per unit
    

(b) Cash-settled derivative transactions

Class of relevant securityProduct descriptione.g. CFDNature of dealinge.g. opening/closing a long/short position, increasing/reducing a long/short positionNumber of reference securitiesPrice per unit
     

(c) Stock-settled derivative transactions (including options)

(i) Writing, selling, purchasing or varying

Class of relevant securityProduct description e.g. call optionWriting, purchasing, selling, varying etc.Number of securities to which option relatesExercise price per unitTypee.g. American, European etc.Expiry dateOption money paid/ received per unit
        

(ii) Exercise

Class of relevant securityProduct descriptione.g. call optionExercising/ exercised againstNumber of securitiesExercise price per unit
     

(d) Other dealings (including subscribing for new securities)

Class of relevant securityNature of dealinge.g. subscription, conversionDetailsPrice per unit (if applicable)
    

4. OTHER INFORMATION

(a) Indemnity and other dealing arrangements

Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the person making the disclosure and any party to the offer or any person acting in concert with a party to the offer:Irrevocable commitments and letters of intent should not be included. If there are no such agreements, arrangements or understandings, state “none”
None

(b) Agreements, arrangements or understandings relating to options or derivatives

Details of any agreement, arrangement or understanding, formal or informal, between the person making the disclosure and any other person relating to:(i) the voting rights of any relevant securities under any option; or (ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced:If there are no such agreements, arrangements or understandings, state “none”
None

(c) Attachments

Is a Supplemental Form 8 (Open Positions) attached?No

Date of disclosure:12/02/2025
Contact name:Chinwe Enyi – Compliance Department
Telephone number:0151 243 7053

Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service.

The Panel’s Market Surveillance Unit is available for consultation in relation to the Code’s disclosure requirements on +44 (0)20 7638 0129.

The Code can be viewed on the Panel’s website at.

Date   Source Headline
17th Jan 20259:11 amRNSHolding(s) in Company
4th Dec 20241:18 pmRNSBoard Change
3rd Dec 202412:41 pmRNSHolding(s) in Company
30th Oct 202412:03 pmRNSHolding(s) in Company
30th Oct 202410:19 amRNSHolding(s) in Company
29th Oct 202411:38 amRNSHolding(s) in Company
7th Oct 20247:00 amRNSConfirmation of CFO Appointment
16th Sep 20243:01 pmRNSDirector/PDMR Shareholding
13th Sep 202410:46 amRNSDirector/PDMR Shareholding
12th Sep 20247:00 amRNSInterim Results
4th Sep 20247:00 amRNSNotice of Results and Investor Presentation
30th Jul 20247:00 amRNSBoard changes
10th Jul 20247:00 amRNSSurrender and grant of options and PDMR dealings
2nd Jul 20247:00 amRNSContract Win
27th Jun 20247:00 amRNSSuccessful conclusion of VAT recoverability case
26th Jun 20247:00 amRNSIntention not to make an offer for Crimson Tide
24th Jun 20245:30 pmRNSForm 8.3 - Checkit Plc
24th Jun 202411:59 amRNSForm 8.5 (EPT/RI)
21st Jun 202410:36 amRNSForm 8.5 (EPT/RI)
20th Jun 202410:47 amRNSForm 8.5 (EPT/RI)
20th Jun 202410:46 amRNSForm 8.3 - Checkit plc - Amendment
19th Jun 202411:54 amRNSForm 8.5 (EPT/RI)
18th Jun 20245:31 pmRNSForm 8.3 - Checkit Plc
18th Jun 20244:23 pmRNSForm 8.3 - Checkit Plc
14th Jun 20246:10 pmRNSForm 8.3 - Checkit PLC
14th Jun 202412:14 pmRNSForm 8.3 - Checkit plc
14th Jun 202411:00 amRNSForm 8.5 (EPT/RI)
14th Jun 20249:42 amRNSForm 8.3 - Checkit plc
13th Jun 202411:37 amRNSForm 8.5 (EPT/RI)
12th Jun 20243:22 pmRNSForm 8 (OPD) - Checkit plc
12th Jun 202411:49 amRNSForm 8.5 (EPT/RI)
12th Jun 20249:29 amRNSForm 8.5 (EPT/RI) - Replacement
12th Jun 20249:19 amRNSForm 8.3 - Checkit plc
12th Jun 20247:00 amRNSContract Wins
11th Jun 20246:15 pmRNSForm 8.3 - Checkit plc - Amendment
11th Jun 20246:14 pmRNSForm 8.3 - Crimson Tide plc - Amendment
11th Jun 202412:04 pmRNSForm 8.5 (EPT/RI)
10th Jun 202412:43 pmEQSForm 8.3 - Apex Fundrock Limited : Form 8.3 - OPD - Checkit PLC
10th Jun 202411:56 amRNSForm 8.5 (EPT/RI) - Checkit PLC
10th Jun 20248:54 amRNSForm 8.3 - Checkit plc
7th Jun 20247:00 amRNSResults of Annual General Meeting
6th Jun 202411:51 amRNSForm 8.5 (EPT/RI)
5th Jun 20245:17 pmRNSForm 8.3 - Checkit plc
5th Jun 20243:06 pmGNWForm 8.3 - Checkit Plc
5th Jun 202411:58 amRNSForm 8.5 (EPT/RI)
5th Jun 202411:57 amRNSForm 8.3 - Checkit PLC
4th Jun 202410:48 amPRNForm 8 (OPD) - Checkit PLC
4th Jun 20247:00 amRNSPossible Offer for Crimson Tide plc
29th Apr 20242:59 pmRNSDirector/PDMR Shareholding
25th Apr 20247:00 amRNSFinal Results

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.